Search

everythinglearnresearchcommunity

for

Search:↓

The conversation discusses hair regrowth using microneedling, Minoxidil, and Finasteride over a three-month period. Specific treatments mentioned are microneedling, Minoxidil (Min), and Finasteride (Fin).

A 19-year-old is using keto shampoo, topical Minoxidil 5% for 3 months, and topical finasteride 0.1% for 1.5 months to address hair loss. They are noticing baby hairs and shedding, questioning if the hairs will thicken and if more time is needed for finasteride to work.

Taking CoQ10 and fish oil supplements may lead to increased body hair growth and a crawling sensation on the scalp and skin. The user suspects these supplements could be linked to hair growth, possibly due to their effects on heart health and cholesterol management.

The user started using finasteride and minoxidil three months ago and reports new hair growth with no side effects. The regimen includes minoxidil foam 5% twice daily, finasteride 1.25 mg daily, and weekly microneedling.

A user shared their significant hair regrowth progress using topical minoxidil, oral finasteride, and minoxidil chews, while transitioning to generic versions. They also mentioned using batana oil and microneedling, with no side effects reported.

The user shared their 12-month hair regrowth progress using 1mg finasteride, 5mg oral minoxidil, and topical minoxidil. They also used a derma stamp weekly and treated seborrheic dermatitis with Mometasone and Nizoral.

A new hair loss treatment, PP405, is moving from phase 2A to 2B in clinical trials, sparking discussions about its potential to regrow dormant hairs and its impact on existing treatments like Minoxidil and finasteride. Some users express skepticism, while others are hopeful about its future effectiveness.

The user is experiencing diffuse androgenic alopecia and is trying various treatments, including 5mg finasteride, loniten, and Formula 82D, which contains dutasteride, a steroid, and tretinoin. They report potential regrowth with Formula 82D, despite previous treatments being ineffective.

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

The conversation discusses a new hair growth product combining rosemary oil, castor oil, argan oil, and jojoba oil. It also mentions the use of Minoxidil, finasteride, and RU58841 for hair loss treatment.